Skip to main content
. 2020 Jul-Sep;32(3):363–373. doi: 10.5935/0103-507X.20200064

Table 1.

Patient characteristics and univariate analysis of septic vs control patients

  Septic (n = 58) Controls (n = 28) p value Total (n = 86)
Demographics and comorbidities
    Sex - male 42 (71.4) 16 (57.1) 0.157 58 (67.4)
    Age ≥ 60 years 18 (31.0) 17 (60.7) < 0.01 35 (40.7)
    Age 55.9 [1.90] 62.0 [4.20] 0.051 57.4 [1.81]
    BMI 27.3 ± 5.5 27.4 ± 4.4 0.916 27.3 ± 5.1
    DM2 16 (27.6) 6 (21.4) 0.540 22 (25.6)
    Arterial hypertension 25 (43.1) 18 (64.3) 0.066 43 (50.0)
    Dyslipidemia 22 (37.9) 13 (46.4) 0.452 35 (40.7)
    Statins use 19 (32.8) 11 (39.3) 0.552 30 (34.9)
    Peripheral arterial disease 12 (20.7) 9 (32.1) 0.247 21 (24.4)
    COPD 10 (10.7) 3 (17.2) 0.529* 13 (15.1)
    Autoimmune disease 5 (8.6) 0 0.168* 5 (4.8)
    Smoking habits 20 (34.5) 8 (28.6) 0.584 28 (32.6)
    Coronary disease 15 (25.9) 9 (32.1) 0.543 24 (27.9)
    Hematological cancer 1 (1.7) 1 (3.6) 0.548* 2 (2.3)
    HIV 9 (15.5) 3 (10.7) 0.743* 12 (14.0)
    Solid neoplasia 5 (8.6) 3 (10.7) 0.712* 8 (9.3)
Clinical variables and severity scores
    APACHE score 21.1 [7.6] 19.1 [5.8) 0.194 20.5 [7.1]
    SAPS 2 score 55.2 [21.1] 55.5 [17.8] 0.953 55.4 [20.0]
    SOFA score 10.1 [4.4] 8.1 [3.3] 0.035 9.5 [4.2]
    Shock 29 (50.0) 9 (32.1) 0.118 38 (44.2)
    MAP (mm Hg) 75.2 [1.70] 81.0 [3.8] 0.064 76.6 [1.60]
    Ionized calcium (mmol/L) 1.12 [0.05] 1.21 [0.03] 0.693 1.15 [0.04]
    pH 7.39 [0.01] 7.42 [0.02] 0.021 7.39 [0.01]
    PaCO2 (mm Hg) 36.9 [1.19] 40.0 [2.89] 0.628 37.6 [1.14]
    Bicarbonate (mmol/L) 21.7 [0.56] 25.6 [1.36] < 0.01 22.3 [0.56]
    Potassium (mEq/L) 4.02 [0.08] 3.7 [0.96] 0.013 3.91 [0.60]
    Temperature (Celsius) 36.8 [0.25] 36.8 [0.15] 0.905 36.8 [0.13]
    Respiratory rate (beats/minute) 19.6 [0.77] 17.5 [1.0] 0.153 19.1 [0.64]
    CRP (mg/L) 102.2 [12.89] 69.3 [15.4] 0.102 97.3 [13.5]
    Lactate (mmol/L) 2.1 [2.2] 1.4 [0.5] 0.022 2.5 [2.5]
    Noradrenaline (mcg/kg/minute) 0.25 [0.50] 0.13 [0.21] 0.105 0.38 [0.59]
    Mortality (28th day) 14 (24.1) 7 (25.0) 0.999 21 (24.4)
Biomarkers and PAT evaluation
    Ln_endocan (pg/mL) 7.07 ± 0.85 7.27 ± 0.58 0.403 7.11 ± 0.79
    Ln_syndecan-1 (pg/mL) 8.61 ± 0.58 8.44 ± 0.53 0.298 8.57 ± 0.57
    Ln_E-selectin (pg/mL) 10.79 ± 0.84 10.19 ± 0.56 0.011 10.66 ± 0.82
    Endothelin-1 (pg/mL) 5.28 ± 3.59 5.80 ± 3.14 0.880 5.69 ± 3.47
    Ln_RHI 0.53 ± 0.48 0.69 ± 0.42 0.122 0.58 ± 0.46
Diagnosis
    Neurological Meningitis: 8 (13.7)
Other: 2 (3.4)
Intracranial hemorrhage: 6 (21.4)
Status epilepticus: 4 (14.3)
Other: 2 (7.1)
- 22 (25.6)
    Pleuropulmonary and cardiovascular Pneumonia: 17 (29.3) Myocardial infarction: 5 - 22 (25.6)
    Intra-abdominal Peritonitis: 5 (8.6)
Pyelonephritis: 4 (6.9)
Other: 2 (3.4)
GI Neoplasia: 2 (7.1)
Pancreatitis: 2 (7.1)
Ischemic colitis: 1 (3.6)
- 16 (27.6)
    Skin and soft tissue NF: 1 (1.7) - - 1 (1.2)
    Systemic Malaria: 10 (17.2)
Bacteremia: 6 (10.3)
Chickenpox: 2 (3.4)
Tuberculosis: 1 (1.7)
Hemorrhagic shock: 3 (10.7)
Polytrauma: 2 (7.1)
Leukemia: 1 (3.6)
- 25 (29.0)
    Confirmed microbiology 43 (74.1) - - -
    Positive blood cultures 24 (41.4) - - -
    Causative organism   - - -
        Gram-positive bacteria 10 (17.2)      
        Gram-negative bacteria 10 (17.2)      
        Atypical bacteria 3 (5.2)      
        Mycobacteria 2 (3.4)      
        Protozoa 10 (17.2)      
        Virus 4 (6.9)      
        Fungus 3 (5.2)      

BMI - body mass index; DM2 - diabetes mellitus II; COPD - chronic obstructive pulmonary disease; APACHEII - Acute Physiology And Chronic Health Evaluation II; SAPS 2 - Simplified Acute Physiology Score 2; SOFA - Sequential Organ Failure Assessment; MAP - mean arterial pressure; PaCO2 – partial pressure of carbon dioxide; CRP - C-reactive protein; PAT - peripheral arterial tonometry; Ln - natural logarithm; NF - necrotizing fasciitis; RHI - reactive hyperemia index.

*

Fischer exact test. Results expressed as n (%), mean ± standard deviation or median [interquartile range].